New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 6, 2014
10:51 EDTRDUSRadius Health opens for trade at $8.03, IPO priced at $8.00
Radius Health (RDUS) priced 6.5M shares at $8.00. Jefferies and Cowen acted as joint book running managers for the offering.
News For RDUS From The Last 14 Days
Check below for free stories on RDUS the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 2, 2014
16:38 EDTRDUSRadius Health files $150M mixed securities shelf
August 28, 2014
17:26 EDTRDUSRadius Health reports proof of mechanism for RAD1901
Radius Health reports that the positron emission tomography imaging from the RAD1901 maximum tolerated dose study has demonstrated potent selective estrogen receptor degradation activity. In the ongoing MTD study, we observed via 18F-fluroestradiol positron emission tomography that a well tolerated dose of RAD1901 strongly suppressed positive baseline estrogen receptor imaging sites in the first healthy volunteer in the PET imaging cohort of the study. The study will continue to test higher doses to determine the maximum tolerated doses and to extend the PET imaging correlation with the pharmacokinetic/pharmacodynamic response to RAD1901. Radius will present these findings as a RAD1901 poster at the 4th Annual Brain Metastases Research and Emerging Therapy Conference, which takes place on September 19-20, 2014 in Marseille, France.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use